Lymphoid Development and Function in X-Linked Severe Combined Immunodeficiency Mice after Stem Cell Gene Therapy-Reference-Cited by-同舟云学术

Lymphoid Development and Function in X-Linked Severe Combined Immunodeficiency Mice after Stem Cell Gene Therapy

Published:2000-02 Issue:2 Volume:1 Page:145-153
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Otsu Makoto,Anderson Stacie M.,Bodine David M.,Puck Jennifer M.,O'Shea John J.,Candotti Fabio

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference37 articles.

1. Human severe combined immunodeficiency: Genetic, phenotypic, and functional diversity in one hundred eight infants;Buckley;J. Pediatr.,1997

2. Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: A European retrospective study of 116 patients;Haddad;Blood,1998

3. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency;Buckley;New Engl. J. Med.,1999

4. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans;Noguchi;Cell,1993

5. The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1;Puck;Hum. Mol. Genet.,1993

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the state of the science for adeno-associated virus integration: An integrated perspective;Molecular Therapy;2022-08

2. Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia;Molecular Therapy - Methods & Clinical Development;2018-12

3. Nuclease-free Adeno-Associated Virus-Mediated Il2rg Gene Editing in X-SCID Mice;Molecular Therapy;2018-05

4. The long terminal repeat negative control region is a critical element for insertional oncogenesis after gene transfer into hematopoietic progenitors with Moloney murine leukemia viral vectors;Gene Therapy;2016-08-04

5. Gene therapy for primary immunodeficiencies;Clinical Genetics;2015-03-23